Opendata, web and dolomites

PREKIND

PreEclampsia diagnosis by Early Kidney Injury Detection

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PREKIND project word cloud

Explore the words cloud of the PREKIND project. It provides you a very rough idea of what is the project "PREKIND" about.

provision    ib    develops    diagnose    infant    plan    contribution    500    women    predict    mayo    accounts    prognostic    lives    health    ambition    business    000    annually    http    podocyte    biomarker    clinical    deaths    disease    75    elisa    preelampsia    clinic    garovic    budgets    7billion    antenatal    leader    diagnosis    exceptional    ongoing    conduct    surviving    ruo    cardiovascular    feasibility    demonstrated    risk    dealing    assays    licensed    pregnancy    form    flow    care    variety    sub    pe    innovation    complications    diagnostic    renal    podocin    too    damage    cytometry    millions    pregnant    introduction    mothers    tests    org    year1    babies    31billion    urine    preeclampsia    claims    foundation    estimates    direct    survive    life    informbio    specificity    solutions    syndrome    world    vesna    worldwide    dr    biomarkers    spend    symptoms    innovative    months    pioneering    annual    sensitivity    emerge3    usa    rest    alone    indicate   

Project "PREKIND" data sheet

The following table provides information about the project.

Coordinator
INFORM BIOSCIENCE LIMITED 

Organization address
address: HOFFMAN PARK LITTLE ISLAND COUNTY CORK
city: CORK
postcode: n.a.
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Project website http://www.informbio.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-05-01   to  2015-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INFORM BIOSCIENCE LIMITED IE (CORK) coordinator 50˙000.00

Map

 Project objective

Health Challenge: PreEclampsia (PE) claims the lives of 75,000 women annually and the 6,000,000 surviving mothers will have an increased risk of cardiovascular disease for the rest of their life. PE accounts for over 500,000 infant deaths worldwide every year1; and for the millions of babies that survive, they too will go on to have increased risk of a variety of health issues. PE is a syndrome that develops during pregnancy but presents no clinical symptoms during most of the pregnancy and is therefore currently complex to diagnose. Business Challenge: With an annual spend of over 31Billion in direct costs in the developed world alone, the provision of antenatal care to pregnant women has a significant impact on health care budgets; dealing with the immediate consequences of PE form an important contribution to this cost. The Preelampsia foundation (http://www.preeclampsia.org/) estimates the annual cost of PE is more than $7billion in the US. InformBio Business Innovation: InformBio (IB) has licensed pioneering research by Dr.Vesna Garovic of the Mayo Clinic, USA. The technology has identified podocyte specific biomarkers in urine that indicate ongoing renal damage and which allow for a sub-clinical diagnosis for PE. The key biomarker, podocin, has demonstrated exceptional sensitivity and specificity and can diagnose the disease up to 3 months before clinical symptoms emerge3. InformBio are currently working to develop flow cytometry and research use only (RUO) ELISA assays for the biomarker. InformBio’s ambition is to be the world leader in early pregnancy prognostic tests, offering the most innovative, cost effective solutions to predict pregnancy complications.

Phase 1 proposal: To conduct a feasibility study to support the development of a detailed business plan for the introduction of a PE diagnostic test.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PREKIND" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PREKIND" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

TT4CL (2019)

Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

Read More  

HELP (2019)

Collaboration for innovation: Establishment of a pan-nematode drug development platform

Read More  

PREFERABLE (2019)

Project on Exercise for Fatigue Eradication in Advanced Breast cancer to improve quality of life

Read More